Training in a Local Community Aimed Upon Musculoskeletal Health Promotion for Postmenopausal Women

December 19, 2021 updated by: Ewa Wulff Helge, University of Copenhagen

A Feasibility Study of Training in a Local Community Aimed Upon Health Promotion With Special Emphasis on Musculoskeletal Health Effects

To minimize fracture risk, diverse and varied training of high intensity (multimodal training) is recommended to increase bone strength. However, the effectiveness of different training programmes performed in community settings remain uncertain. The present study aimed to evaluate the feasibility and the effectiveness of 19-week of multimodal training in a local community center in Copenhagen, Denmark. The health promotion initiative had special emphasis on musculoskeletal health in postmenopausal women.

Study Overview

Status

Completed

Detailed Description

A local community center was offering supervised multimodal training (MMT) to postmenopausal, healthy women twice weekly, and the aim of the present study was to evaluate the feasibility and the musculoskeletal health promoting effects of the training. The evaluation study lasted for 19 weeks, and the average attendance rate of MMT participants had to be > 1 hour weekly. The primary outcomes were bone mineral density (BMD) assessed by Dual-Energy X-ray Absorptiometry (DXA) scanning and the fasted plasma concentration of bone turnover markers (BTM): N-terminal propeptide of type I procollagen (P1NP) , C-terminal telopeptide of type I collagen (CTX), Osteocalcin), while secondary outcomes were body composition variables, dynamic postural balance and functional muscle strength. To test within- and between-group differences in the pre and post outcomes the training group (MMT) was compared with a sedentary control group (CON).

Every participant was fully informed before giving her written informed consent to the procedures and potential discomfort associated with the study. The study was conducted in accordance with the Declaration of Helsinki and approved by the local ethics committee of the Capital Region of Denmark, H-18044190.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2200
        • University of Copenhagen, Department of Nutrition, Exercise and Sports

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 70 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • past menopause
  • non-smoking
  • BMI <30 kg/m2

Exclusion Criteria:

  • T-score < -3 SD in the lumbar spine or hip
  • Z-score > 1.5 SD)
  • use of hormone therapy, medical treatment or supplements that affect bone metabolism
  • previous or current medical condition affecting bone health
  • engagement in regular and systemic weight-bearing training or strength training during the preceding two years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MMT
Intervention group performing multimodal training (MMT) 1-2 hours weekly
Supervised multimodal exercise training (MMT) performed 1-2 hours weekly for 19 weeks
Other Names:
  • Sedentary control group (CON)
No Intervention: CON
Sedentary control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Whole-body and regional BMD
Time Frame: 19 weeks
bone mineral density (g/cm2)
19 weeks
Osteocalcin
Time Frame: 3 weeks and 19 weeks
Concentration of Osteocalcin in plasma in fasted state (µg/l)
3 weeks and 19 weeks
P1NP
Time Frame: 3 weeks and 19 weeks
Concentration of P1NP in plasma in fasted state (µg/l)
3 weeks and 19 weeks
CTX
Time Frame: 3 weeks and 19 weeks
Concentration of CTX in plasma in fasted state (ng/l)
3 weeks and 19 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body fat percentage
Time Frame: 19 weeks
Body fat percentage (%)
19 weeks
Visceral adipose tissue (VAT)
Time Frame: 19 weeks
Volume (m3)
19 weeks
Body weight
Time Frame: 19 weeks
kg
19 weeks
BMI
Time Frame: 19 weeks
kg/m2
19 weeks
Total fat mass
Time Frame: 19 weeks
kg
19 weeks
Total lean body mass (LBM)
Time Frame: 19 weeks
kg
19 weeks
Whole-body bone mineral content (BMC)
Time Frame: 19 weeks
g
19 weeks
dynamic balance
Time Frame: 19 weeks
time to fulfill a four-square-balance test (sec)
19 weeks
dynamic muscle strength
Time Frame: 19 weeks
Jump-and-reach-test (cm)
19 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eva W Helge, Ph.D., University of Copenhagen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 4, 2019

Primary Completion (Actual)

July 9, 2019

Study Completion (Actual)

July 9, 2019

Study Registration Dates

First Submitted

December 4, 2021

First Submitted That Met QC Criteria

December 19, 2021

First Posted (Actual)

December 21, 2021

Study Record Updates

Last Update Posted (Actual)

December 21, 2021

Last Update Submitted That Met QC Criteria

December 19, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Age-Related Osteoporosis

Clinical Trials on multimodal training (MMT)

Subscribe